Invention Grant
- Patent Title: Thiazolyl compounds useful as kinase inhibitors
- Patent Title (中): 可用作激酶抑制剂的噻唑基化合物
-
Application No.: US12519597Application Date: 2007-12-19
-
Publication No.: US08148400B2Publication Date: 2012-04-03
- Inventor: Anne Marinier , Claude A. Quesnelle , Marco Dodier , Stephan Roy , Patrice Gill , Mark D. Wittman , David R. Langley
- Applicant: Anne Marinier , Claude A. Quesnelle , Marco Dodier , Stephan Roy , Patrice Gill , Mark D. Wittman , David R. Langley
- Applicant Address: US NJ Princeton
- Assignee: Bristol-Myers Squibb Company
- Current Assignee: Bristol-Myers Squibb Company
- Current Assignee Address: US NJ Princeton
- Agent Elliott Korsen
- International Application: PCT/US2007/088124 WO 20071219
- International Announcement: WO2008/079873 WO 20080703
- Main IPC: C07D417/14
- IPC: C07D417/14 ; C07D495/04 ; A61K31/4436
Abstract:
The invention provides compounds of formula II: and pharmaceutically acceptable salts thereof. The formula II thiazolyl compounds inhibit tyrosine kinase activity thereby making them useful as anticancer agents and for the treatment of Alzheimer's Disease.
Public/Granted literature
- US20100048581A1 THIAZOLYL COMPOUNDS USEFUL AS KINASE INHIBITORS Public/Granted day:2010-02-25
Information query
